GGrantIndex
Sort

40,608 grants matching prostate cancer

Genetic profiling in PCPT: prostate cancer risk, PSA levels, and chemoprevention

$641,014
Jianfeng Xu · Wake Forest University Health Sciences · R01 · FY2009 · CA

Multilevel Interventions to Increase Adherence to Lung Cancer Screening

$641,003
Karen J Wernli · Kaiser Foundation Research Institute · R01 · FY2023 · CA

Evaluating Lung Cancer Screening Patterns and Outcomes through a North Carolina Registry

$640,870
Louise Henderson · Univ Of North Carolina Chapel Hill · R01 · FY2018 · CA

Effect of Aerobic Exercise on Genomic Signatures of Prostate Cancer Prognosis

$640,862
June Ml Chan · University Of California, San Francisco · R01 · FY2015 · CA

Growth Factors and Lethal Prostate Cancer Signature

$640,710
Meir J Stampfer · Brigham And Women'S Hospital · R01 · FY2010 · CA

Protein kinase C and lung carcinogenesis

$640,695
Marcelo Gabriel Kazanietz · University Of Miami School Of Medicine · R01 · FY2024 · CA

Single-molecule nanopore-based identification of methylome signatures in cfDNA for early colorectal cancer detection

$640,695
Hanlee Ji · Stanford University · U01 · FY2025 · CA

Project-1: Defining the mechanisms by which neurons promote breast cancer metastasis

$640,681
Sohail F. Tavazoie · Rockefeller University · U54 · FY2023 · CA

Multi-Modality MRI/CT Markers for Improved Assessment of Prostate Cancer

$640,660
Andrew Bright · C4 Imaging, Llc · R44 · FY2016 · CA

Interactions of Androgen Production, Uptake and Metabolism on outcome in Castration Resistant Prostate Cancer

$640,563
Charles James Ryan · University Of Minnesota · R01 · FY2022 · CA

Biostatistics Core

$640,535
Qi Long · University Of Pennsylvania · P30 · FY2020 · CA

Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ

$640,470
Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

Tumor stem cells and metastatic outcomes in mouse models of prostate cancer

$640,431
Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Carolina Community Network Center to Reduce Cancer Health Disparities (CCN II)

$640,418
Paul A. Godley · Univ Of North Carolina Chapel Hill · U54 · FY2014 · CA

(PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment

$640,378
John V Frangioni · Curadel, Llc · R01 · FY2017 · CA

Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies

$640,260
Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2024 · CA

Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways

$640,123
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion

$640,123
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Advanced diffusion MRI for evaluating early response to radiation treatment in cervical cancer

$640,083
Rebecca Ann Rakow-Penner · University Of California, San Diego · R37 · FY2021 · CA

Support of Training and Mentoring in Nigeria for Academics (STAMINA)

$640,000
Atiene Solomon Sagay · University Of Jos · D43 · FY2015 · TW

Support of Training and Mentoring in Nigeria for Academics (STAMINA)

$640,000
Atiene Solomon Sagay · University Of Jos · D43 · FY2019 · TW

Support of Training and Mentoring in Nigeria for Academics (STAMINA)

$640,000
Atiene Solomon Sagay · University Of Jos · D43 · FY2017 · TW

Support of Training and Mentoring in Nigeria for Academics (STAMINA)

$640,000
Atiene Solomon Sagay · University Of Jos · D43 · FY2016 · TW

Support of Training and Mentoring in Nigeria for Academics (STAMINA)

$640,000
Atiene Solomon Sagay · University Of Jos · D43 · FY2018 · TW

Registering Cancer Recurrences in the Georgia Cancer Registry

$639,928
Kevin C Ward · Emory University · R01 · FY2021 · CA